Auro Laboratories Limited informs you that the Board of Directors at their Meeting held today (i.e. Friday, January 28, 2022), has transacted the following business:<BR> <BR> Approved the Un-Audited Standalone Financial Results of the Company for the quarter ended on December 31, 2021 as recommended by the Audit Committee.<BR> <BR> Pursuant to Regulation 33 of SEBI (LODR) Regulations, 2015, we are enclosing herewith the following:<BR> <BR> 1.) Un-Audited Standalone Financial Results for the quarter ended December 31, 2021. <BR> 2.) Limited Review Report received from the Statutory Auditor of the Company.<BR> <BR>
|